Karex Berhad, an investment holding company, (5247) Fair Value & Analysis
Consumer Defensive · MY · Market cap 495M MYR
Fair value as of: Jun 24, 2026
Analysis
Karex Berhad, an investment holding company, (5247) currently trades at 0.4900 MYR, while our model-based Fair Value estimate is 0.2600 MYR — implying the stock looks roughly 46.9% overvalued today. We read business quality at 95/100 (high quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
Karex Berhad, an investment holding company, manufactures and sells condoms in Malaysia. The company provides personal lubricants; probe covers; and catheters for transurethral drainage of the urinary bladder, as well as gloves. It also offers hand sanitizer and pre-vulcanised latex products. In addition, the company engages in wholesale healthcare product related business. Karex Berhad operates in the Americas, Asia, Europe, and Africa. Karex Berhad serves brand owners, governments, non-governmental organizations, and retail purchasers. The company was founded in 1988 and is based in Port Klang, Malaysia.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Karex Berhad, an investment holding company, (5247) undervalued?
What is the fair value of 5247?
What is the quality score of 5247?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.